These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26476705)

  • 1. Effects of haloperidol and aripiprazole on the human mesolimbic motivational system: A pharmacological fMRI study.
    Bolstad I; Andreassen OA; Groote I; Server A; Sjaastad I; Kapur S; Jensen J
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2252-61. PubMed ID: 26476705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Effects of an Acute Dose of Antipsychotic Medication on Motivation-mediated BOLD Activity Using fMRI and a Perceptual Decision-making Task.
    Delfin C; Reckless GE; Bolstad I; Groote I; Andreassen OA; Jensen J
    Neuroscience; 2020 Aug; 440():146-159. PubMed ID: 32473275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aripiprazole and haloperidol on neural activation during the n-back in healthy individuals: A functional MRI study.
    Goozee R; Reinders AATS; Handley R; Marques T; Taylor H; O'Daly O; McQueen G; Hubbard K; Mondelli V; Pariante C; Dazzan P
    Schizophr Res; 2016 Jun; 173(3):174-181. PubMed ID: 25778615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study.
    Goozee R; O'Daly O; Handley R; Reis Marques T; Taylor H; McQueen G; Hubbard K; Pariante C; Mondelli V; Reinders AA; Dazzan P
    Hum Brain Mapp; 2017 Apr; 38(4):1833-1845. PubMed ID: 28009070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol.
    Bolstad I; Andreassen OA; Groote IR; Haatveit B; Server A; Jensen J
    Front Hum Neurosci; 2015; 9():296. PubMed ID: 26074803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain.
    Handley R; Zelaya FO; Reinders AA; Marques TR; Mehta MA; O'Gorman R; Alsop DC; Taylor H; Johnston A; Williams S; McGuire P; Pariante CM; Kapur S; Dazzan P
    Hum Brain Mapp; 2013 Feb; 34(2):272-82. PubMed ID: 22451196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation.
    Menon M; Jensen J; Vitcu I; Graff-Guerrero A; Crawley A; Smith MA; Kapur S
    Biol Psychiatry; 2007 Oct; 62(7):765-72. PubMed ID: 17224134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers.
    Handley R; Mondelli V; Zelaya F; Marques T; Taylor H; Reinders AATS; Chaddock C; McQueen G; Hubbard K; Papadopoulos A; Williams S; McGuire P; Pariante C; Dazzan P
    Schizophr Res; 2016 Jul; 174(1-3):99-105. PubMed ID: 27112637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation.
    Schlagenhauf F; Dinges M; Beck A; Wüstenberg T; Friedel E; Dembler T; Sarkar R; Wrase J; Gallinat J; Juckel G; Heinz A
    Schizophr Res; 2010 May; 118(1-3):189-200. PubMed ID: 20189356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-induced changes in neural network patterns supporting aversive conditioning.
    Diaconescu AO; Menon M; Jensen J; Kapur S; McIntosh AR
    Brain Res; 2010 Feb; 1313():143-61. PubMed ID: 19961836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.
    Young KA; Franklin TR; Roberts DC; Jagannathan K; Suh JJ; Wetherill RR; Wang Z; Kampman KM; O'Brien CP; Childress AR
    J Neurosci; 2014 Apr; 34(14):5038-43. PubMed ID: 24695721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers.
    McCabe C; Huber A; Harmer CJ; Cowen PJ
    Psychopharmacology (Berl); 2011 Sep; 217(2):271-8. PubMed ID: 21494790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
    Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
    J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.
    Murphy A; Dursun S; McKie S; Elliott R; Deakin JF
    Psychopharmacology (Berl); 2016 Apr; 233(8):1415-26. PubMed ID: 26900078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol.
    Lum JS; Pan B; Deng C; Huang XF; Ooi L; Newell KA
    Psychiatry Res; 2018 Feb; 260():152-157. PubMed ID: 29195167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M; Huang XF; Deng C
    Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
    Oshibuchi H; Inada K; Sugawara H; Ishigooka J
    Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.